Our study reveals that DSF/Cu regulates autophagy to inhibit proliferation in colorectal cancer through the ULK1 pathway, which provides new evidence for employing this existing drug toward a novel anticancer use. This evidence concerns the gene ULK1 and colorectal cancer.